Q-omics provides the consensus-scored RN7SL479P profile across patient tissues and cancer cell-line models. RN7SL479P expression is associated with patient survival in 10 of 34 cancer types, with the highest sampling consensus in LIHC. Additionally, RN7SL479P RNA expression shows 5,704 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight LIHC, and STAD as cancer lineages where RN7SL479P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.